Biosynergen, Inc.
Records under this name other than patents Biosynergen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 1 of 1 · Back to Biosynergen, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,410,955 | Therapeutic use of agonist ligands specific to G2A receptor Formerly held Term ended Term ended Mar 25, 2023 · From the USPTO record | Term ended | Term ended Mar 25, 2023 | From the USPTO record |